Dr. Erin Hofstatter gives some "red flags" that indicate a patient or family member should consider genetic counseling and testing.
Erin Hofstatter, MD, from Smilow Cancer Hospital and Yale Medical School, gives some indications that should prompt a patient or family member to go for genetic counseling and testing.
Hofstatter goes over the “classic red flags” that can indicate hereditary cancer risk and a need for genetic counseling and testing, including patients or family members diagnosed at a younger age or if the family history has a clustering of breast and ovarian cancer, or breast, ovarian and pancreatic cancers.
Workflow, Educational Tools Improve Use of Silicone Film to Prevent Radiation Dermatitis
April 25th 2024Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to patients with breast cancer, as well as its application and maintenance.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.